(Q77872001)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365809%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365809%20AND%20SRC:MED&resulttype=core&format=json

primary biliary cholangitis

8 December 2019

main subject

0 references

author name string

P Angulo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365809%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

E R Dickson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365809%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

T M Therneau

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365809%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

R A Jorgensen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365809%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

C Smith

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365809%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

C K DeSotel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365809%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

S M Lange

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365809%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

M L Anderson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365809%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

D W Mahoney

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365809%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

K D Lindor

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365809%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 May 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365809%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365809%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365809%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365809%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

830-835

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365809%20AND%20SRC:MED&resulttype=core&format=json

Management of primary biliary cirrhosis and autoimmune cholangitis

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980136-6

7 January 2021

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980136-6

7 January 2021

Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980136-6

7 January 2021

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980136-6

7 January 2021

Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980136-6

7 January 2021

Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980136-6

7 January 2021

Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980136-6

7 January 2021

Ursodeoxycholic acid: a safe and effective agent for dissolving cholesterol gallstones

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980136-6

7 January 2021

Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980136-6

7 January 2021

Effect of ursodeoxycholic acid in chronic hepatitis and primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980136-6

7 January 2021

Characterisation of patients with a complete biochemical response to ursodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980136-6

7 January 2021

Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980136-6

7 January 2021

Effect of different doses of ursodeoxycholic acid in chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980136-6

7 January 2021

Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980136-6

7 January 2021

Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980136-6

7 January 2021

Prognosis in primary biliary cirrhosis: model for decision making

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980136-6

7 January 2021

Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980136-6

7 January 2021

Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980136-6

7 January 2021

Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980136-6

7 January 2021

Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980136-6

7 January 2021

10.1016/S0168-8278(99)80136-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10365809%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference